300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Angel Investors (May 2026)

The most active angel investors investing in Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
26 United Kingdom, United States, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $430k–$50M
Milad Alucozai
Angel
20 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $91k–$60M
Jude Gomila
Angel
11 United States, United Kingdom, Canada Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $190k–$3.1M
Jeff Dean
Angel
10 United States, United Kingdom Seed, Series A, Series B Artificial Intelligence, Biotechnology, Health Care $1.5M–$53M
Jaffray Woodriff
Angel
10 United States Seed, Series A, Angel Software, Biotechnology, Health Care $640k–$11M
Paul Buchheit
Angel
10 United States, Canada, India Seed, Series A, Angel Software, Health Care, E-Commerce $100k–$8.5M
Jim Mellon
Angel
9 United States, United Kingdom, Israel Series A, Seed Biotechnology, Health Care, Food and Beverage $503k–$20M
bumpkins profile
Angel
9 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Software $325k–$14M
Kingsley Advani
Angel
9 United States, Singapore, United Kingdom Seed, Pre-Seed, Series A FinTech, Financial Services, Biotechnology $120k–$183M
Alice Zhang
Angel
8 United States, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $120k–$5.9M
Wei Guo
Angel
7 United States, China, Canada Seed, Series A, Angel Software, Artificial Intelligence, Health Care $150k–$33M
Zach Weinberg
Angel
6 United States, Israel, Colombia Seed, Series A, Series B Health Care, Software, Medical $750k–$40M
Chris Gibson
Angel
6 United States, France, United Kingdom Series A, Seed Biotechnology, Pharmaceutical, Health Care
Evan Cheng
Angel
6 United States, United Kingdom, Australia Seed, Pre-Seed, Series A Software, Artificial Intelligence, Biotechnology $50k–$3.1M
Jeff Hammerbacher
Angel
6 United States Seed, Series A, Angel Software, Artificial Intelligence, Biotechnology $1M–$20M
Nadav Rosenberg
Angel
6 United Kingdom, Israel, Singapore Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Pharmaceutical $2M–$2M
Farzad (Zod) Nazem
Angel
5 United States, Canada Seed, Series A, Series B Health Care, Analytics, Machine Learning $650k–$31M
Stefano Bernardi
Angel
5 Italy, France, Norway Seed, Pre-Seed Software, Biotechnology, Cryptocurrency $2M–$2M
Cory Levy
Angel
5 United States, United Kingdom Pre-Seed, Seed, Grant Software, Artificial Intelligence, Machine Learning $125k–$7M
Kevin Moore
Angel
5 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $120k–$3M
Sam Altman
Angel
5 United States, Ghana, Canada Seed, Series A, Series B Software, Internet, E-Commerce $1.2M–$100M
Peter Thiel
Angel
5 United States, Germany, Canada Series A, Seed, Series B Software, FinTech, Financial Services $600k–$105M
Charlie Songhurst
Angel
5 United States, United Kingdom, Germany Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $360k–$6.4M
David R. Walt
Angel
5 United States Seed, Series A, Series B Biotechnology, Genetics, Life Science $2M–$5M
Erik Peterson
Angel
5 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, Biotechnology, SaaS $69k–$20M
Bradley Horowitz
Angel
5 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Health Care $125k–$50M
Nat Turner
Angel
4 United States, China Seed, Series A, Series B Health Care, Software, Medical $650k–$26M
John D'Orazio
Angel
4 United States Seed, Equity Crowdfunding Biotechnology, Medical, Health Care $245k–$810k
Eric Kwan
Angel
4 United States, India, Canada Seed, Pre-Seed Software, FinTech, E-Commerce $125k–$9.5M
Jack Abraham
Angel
4 United States Seed, Series A, Series B Health Care, Biotechnology, Fitness $1M–$10M
T. Chen Fong
Angel
4 Canada, Singapore, United States Seed, Angel Software, Artificial Intelligence, Biotechnology $872k–$5M
Bernard Majoie
Angel
4 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care
Mark Cuban
Angel
4 United States, United Kingdom, Singapore Seed, Series A Software, Blockchain, Artificial Intelligence $600k–$23M
Sahin Boydas
Angel
4 United States, Mexico, Spain Series A, Seed, Series B Software, Financial Services, FinTech $4M–$70M
Andrea Dusi
Angel
4 Italy, United States, United Kingdom Seed, Pre-Seed, Series A Biotechnology, Health Care, Information Technology $911k–$6M
Darrin Disley
Angel
4 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $430k–$3.7M
Daren Cotter
Angel
4 United States Seed, Series A Software, E-Commerce, Health Care $300k–$10M
Max Levchin
Angel
4 United States, United Kingdom, India Series A, Seed, Series B FinTech, Financial Services, Mobile $1.3M–$116M
Annie Vereecken
Angel
4 Belgium Seed, Series A Biotechnology, Medical, Hospital
Sake Bosch
Angel
4 The Netherlands, France, Israel Series A, Seed, Series B Software, E-Commerce, Food and Beverage $1.8M–$78M
Brad Flora
Angel
4 United States, Mexico, India Seed, Pre-Seed, Series A Software, FinTech, Financial Services $350k–$3.6M
Bill Gates
Angel
4 United States, Canada, Israel Series A, Series C, Series B Energy, Biotechnology, Manufacturing $12M–$100M
Brenton Saunders
Angel
4 United States Seed, Series A, Series B Health Care, Medical, Biotechnology
David Beyer
Angel
4 United States Seed, Series A, Angel Software, Artificial Intelligence, Enterprise Software $500k–$9M
Arda Kara
Angel
4 United States, Germany, Switzerland Series A, Seed, Series B Health Care, Medical, Software $25M–$27M
Esther Dyson
Angel
4 United States, Canada, Russian Federation Seed, Series A Health Care, Medical, Software $100k–$9.7M
Ling Wong
Angel
4 United States Series A, Series B, Series C Biotechnology, Health Care, Medical $32M–$300M
Ian Hogarth
Angel
4 United Kingdom, United States, Germany Seed, Pre-Seed, Series A Software, E-Commerce, Health Care $123k–$12M
Elad Gil
Angel
4 United States, United Kingdom, Israel Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$75M
Ethan Oren Perlstein
Angel
4 United States, Canada Seed Biotechnology, Cannabis, Biopharma $2M–$4.5M
Access all 1317 angel investors in Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 26 investments in Biotechnology startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 44
  • Round size: Seed $430k–$10M; Series A $1.8M–$18M; Series B $1.8M–$50M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 20 investments in Biotechnology startups

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $91k–$4.5M; Pre-Seed $107k–$1.4M; Series A $25M–$60M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 11 investments in Biotechnology startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 50
  • Round size: Seed $1.2M–$3.1M; Angel $190k–$1.3M; Pre-Seed $1.2M–$2M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • Monitaur — Reduce operational overhead, improve security, optimize performance, and deliver amazing customer experiences with our end-to-end, hybrid observability & APM platform built for decentralized apps and infrastructure.
  • Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 10 investments in Biotechnology startups, 9 in the past 12 months

Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a co­designer and co­implementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open­-source system for machine learning.​Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM­-Infosys Foundation Award in the Computing Sciences.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 30
  • Round size: Seed $1.5M–$12M; Series A $6.1M–$20M; Series B $53M–$53M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Luda — Lifting people through play
  • Elicit — Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers.
  • Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Jaffray Woodriff
Angel · Charlottesville, Virginia, United States · 10 investments in Biotechnology startups

Angel Investor located in Charlottesville, VA

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 43
  • Round size: Seed $640k–$4.3M; Angel $810k–$2.6M; Series A $3.4M–$11M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
  • Fringe — With 100+ vendors, Fringe offers an employee lifestyle benefits experience that builds loyalty, productivity, and well-being. Learn more to get started!
  • Starchive — Built by creators for creators, to maximize the control and ownership of their media, community, and commerce in the Visual Economy.
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 10 investments in Biotechnology startups

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 102
  • Round size: Seed $1M–$5M; Angel $100k–$1M; Series A $650k–$8.5M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
  • Character.ai — character.ai is bringing to life the science-fiction dream of open-ended conversations and collaborations with computers.
  • Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Jim Mellon
Angel · 9 investments in Biotechnology startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Food and Beverage
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 26
  • Round size: Seed $503k–$20M; Series A $2.8M–$4.3M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Amy — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Show all investments...

bumpkins profile
Angel · 9 investments in Biotechnology startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.9M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Show all investments...

Kingsley Advani
Angel · San Francisco, California, United States · 9 investments in Biotechnology startups

Kingsley Advani is a British investor. He started investing in 2013, funding 50 companies, 4 funds and donating to non-profits including: SENS Foundation, Methuselah Foundation, Stanford University, National University of Singapore. He is particularly interested in regenerative medicine for age-related disease. Investments: Oisin, Turn Bio,Oncosenx, Monzo, Robinhood, Abra, Coinbase, Momentus, Demonpores, 64-x, Nectome. Investment areas: biotechnology, neurotechnology, longevity, space, fintech.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 44
  • Round size: Seed $120k–$4M; Pre-Seed $120k–$3M; Series A $4M–$183M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Checkstep — CheckStep provides a AI-powered Trust & Safety and UGC management software to online platform worldwide. It enables company to manage the full policy management life-cycle.
  • Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
  • Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
Show all investments...

Alice Zhang
Angel · San Francisco, California, United States · 8 investments in Biotechnology startups

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $120k–$5.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Wei Guo
Angel · San Francisco, California, United States · 7 investments in Biotechnology startups

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 138
  • Round size: Seed $150k–$4.3M; Angel $375k–$1.7M; Series A $3.8M–$33M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
  • Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
  • Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.
Show all investments...

Zach Weinberg
Angel · New York, New York, United States · 6 investments in Biotechnology startups

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, Colombia

Investor stats

  • Total investments: 68
  • Round size: Seed $750k–$5M; Series A $1M–$15M; Series B $18M–$40M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 6 investments in Biotechnology startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 8
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Amenities — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Show all investments...

Evan Cheng
Angel · Burlingame, California, United States · 6 investments in Biotechnology startups

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Australia

Investor stats

  • Total investments: 21
  • Round size: Seed $50k–$3.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PARSIQ — Comprehensive tools for analyzing, detecting, and preventing cryptocurrency fraud.
  • Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
  • Kernal Biologics — Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA
Show all investments...

Jeff Hammerbacher
Angel · 6 investments in Biotechnology startups

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 25
  • Round size: Seed $1M–$20M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Vectara — Put Generative AI into action with Vectara's end-to-end LLM pipeline, Grounded Generation, & APIs (Vectors, Hybrid Search, Summarization)
  • Lambda — GPU Workstations, GPU Servers, GPU Laptops, and GPU Cloud for Deep Learning & AI. RTX 3090, RTX 3080, RTX A4000, RTX A5000, RTX A6000, and A100 Options. Ubuntu, TensorFlow, and PyTorch Pre-Installed.
  • Together — Together will enable researchers, developers & companies to leverage and improve artificial intelligence with an intuitive data, models & computation platform.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 6 investments in Biotechnology startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Pharmaceutical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Israel, Singapore

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • thymia — Making mental health as objectively measurable as physical health.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Show all investments...

Farzad (Zod) Nazem
Angel · Palo Alto, California, United States · 5 investments in Biotechnology startups

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Show more...

Investment focus

  • Industry: Health Care, Analytics, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 36
  • Round size: Seed $650k–$11M; Series A $4.2M–$31M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
  • Ceevra, Inc. — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
  • TigerGraph — TigerGraph is the fastest and only scalable graph database for the enterprise. Unleash the power and speed of our graph analytics platform today.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Cryptocurrency
  • Stage:Seed, Pre-Seed
  • Geography: Italy, France, Norway

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Freatic — We bridge the gap between individuals with untapped knowledge and actors who can take advantage of these opportunities.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Show all investments...

Cory Levy
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups, 13 in the past 12 months

Cory Levy is the Founder Advisor of Humaning.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Pre-Seed, Seed, Grant
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 34
  • Round size: Seed $1.1M–$7M; Pre-Seed $125k–$1.1M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • 0xPass — Frictionless auth and login for your dapp
  • Onboard AI — Tabnam is an AI-powered product research tool that scrapes the internet for customer experience data about a product to help shoppers make more informed decisions.
  • Induced AI — Induced AI works to automate browser tasks. It runs a cloud to complete manual tasks on a browser with human-like reasoning capabilities.
Show all investments...

Kevin Moore
Angel · Dallas, Texas, United States · 5 investments in Biotechnology startups

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 97
  • Round size: Seed $120k–$3M; Pre-Seed $120k–$2.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Augmend — AI-augmented knowledge transfer across developers through a platform that captures and shares expertise.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sam Altman
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups, 17 in the past 12 months

Sam Altman is the co-founder and CEO of OpenAI. Sam was previously the Chairman of Y Combinator, a leading silicon valley startup accelerator.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Seed, Series A, Series B
  • Geography: United States, Ghana, Canada

Investor stats

  • Total investments: 143
  • Round size: Seed $1.2M–$10M; Series A $4M–$36M; Series B $23M–$100M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Induced AI — Induced AI works to automate browser tasks. It runs a cloud to complete manual tasks on a browser with human-like reasoning capabilities.
  • teachme.to — Teachme.to is a community of learners discovering lessons for everything.
  • Vital Bio — Reinventing diagnostics for proactive & accessible care. Diagnostics designed for better outcomes. Eliminating gaps between care and treatment.
Show all investments...

Peter Thiel
Angel · San Francisco, California, United States · 5 investments in Biotechnology startups, 17 in the past 12 months

Peter Thiel Is The Member, Board of Directors At Facebook. Founder at Breakout Labs.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 177
  • Round size: Seed $600k–$5.8M; Series A $1.6M–$18M; Series B $10M–$105M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
  • Alias Technologies — Here at Alias Technologies our goal is to help organizations tackle complex IT goals and initiatives in an ever-changing landscape. Leveraging our Partner relationships and extensive experience we are able to help position our customers for the future.
  • Treasure Financial — An automated cash flow tool for businesses and startups. Get started today, all you need is 15 minutes to maximize your existing cash.
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 5 investments in Biotechnology startups, 20 in the past 12 months

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 136
  • Round size: Seed $1M–$6.4M; Pre-Seed $360k–$3.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • DGG — 3D production teams rely on RapidCompacts speed, quality, and scalability to meet the growing demand for 3D content.
  • Story Protocol — Story Protocol is building open IP infrastructure to grow the creativity of the internet era.
  • Borderless — Borderless is a workforce migration platform.It offers automation solutions that focuses on all aspects of hiring and onboarding of foreign workers, including recruitment, immigration, relocation, and compliance.
Show all investments...

David R. Walt
Angel · Boston, Massachusetts, United States · 5 investments in Biotechnology startups

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Show more...

Investment focus

  • Industry: Biotechnology, Genetics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 8
  • Round size: Seed $2M–$5M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
  • Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 5 investments in Biotechnology startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 59
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 5 investments in Biotechnology startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 92
  • Round size: Seed $125k–$12M; Series A $5M–$31M; Series B $19M–$50M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • T2 — T2 is in early alpha. 280 character text, replies, and likes - that's it for now. Browse content now and sign up for the waitlist.
  • Mill — So long, smelly bags. Goodbye, greenhouse gasses. Reserve your membership today and make a real difference from your kitchen.
  • Meander — Vektor is the career platform for Tech professionals.
Show all investments...

Nat Turner
Angel · New York, New York, United States · 4 investments in Biotechnology startups

Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, China

Investor stats

  • Total investments: 71
  • Round size: Seed $650k–$5M; Series A $1M–$15M; Series B $18M–$26M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
  • Collectors — Helping collectors to pursue their passion.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Show all investments...

John D'Orazio
Angel · New York, New York, United States · 4 investments in Biotechnology startups

John is the Founder and CEO of Capture Collective.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Equity Crowdfunding
  • Geography: United States

Investor stats

  • Total investments: 16
  • Round size: Seed $245k–$810k
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • RenovoDerm — A medical device company building a line of wound care products that provide a structure for tissue growth and promote faster healing of wounds—while reducing scar tissue. Funding prior to formation: $1.6 million.
  • Vascular Genesis — A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products -- with self-healing capabilities that lower the risk of rejection, infection, and stenosis. Funding prior to formation: $2.5 million.
  • Atreon Orthopedics — A medical device company building a line of orthopedic products that provide a structure for tissue growth and healing of sports medicine injuries including tendon ruptures/tears.
Show all investments...

Eric Kwan
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

Show more...

Investment focus

  • Industry: Software, FinTech, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 54
  • Round size: Seed $1M–$9.5M; Pre-Seed $125k–$913k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Treinta — Treinta is a digital ledger app for Latin American microbusinesses. Through Treinta, users can easily record transactions by assigning products from their inventory and see how their business metrics evolve in real time. The app helps owners save up to 30 minutes a day in bookkeeping related tasks and improve efficiency by over 30%. Out of the 50million microbusinesses in LATAM, today 90% still track their sales and expenses by using pen and paper.
  • Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
  • Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot
Show all investments...

Jack Abraham
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

Jack is the Founder and Managing Partner of Atomic, a venture studio that is investing out of its second $150M fund that has co-founded over a dozen companies.  Atomic and its companies have raised over $550M over the past several years.  Jack is also an angel investor in companies such as Uber, Pinterest, Flatiron Health and Postmates which heoriginally gave the founders the idea of.  Previously Jack founded Milo.com, a local shopping search engine that was acquired by Ebay for $75M.Jack also serves as the executive director of the Thiel Fellowship.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Fitness
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 28
  • Round size: Seed $1M–$9M; Series A $5M–$10M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • OneAdvisory — OneAdvisory helps independent financial advisors to build ideal firms through strategic investments and advanced technology. The company was founded in 2022 and is headquartered in Miami, Florida.
  • Wally Health — Unlimited dental cleanings and whitening for $199/year
  • NUE Life Health — NUE Life aims to improve mental wellness by enhancing brain function, performance, and longevity through evidence based and scientifically proven mental health treatments and products.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
T. Chen Fong
Angel · Calgary, Alberta, Canada · 4 investments in Biotechnology startups

Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Angel
  • Geography: Canada, Singapore, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $872k–$5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
  • SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
  • Cadence — Cadence's Executor Assistant helps surviving family members to complete benefits claims, notifications, account subscriptions, and other tasks after a death.
Show all investments...

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 4 investments in Biotechnology startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

Mark Cuban
Angel · Dallas, Texas, United States · 4 investments in Biotechnology startups, 14 in the past 12 months

Mark Cuban is the founder of Fireside, Chairman and Founding partner of AXS TV, and the Owner of Dallas Mavericks. Prior to that, he was the Co-Founder of Broadcast.com. Mrk attended the Indiana University Bloomington.

Show more...

Investment focus

  • Industry: Software, Blockchain, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 153
  • Round size: Seed $600k–$5M; Series A $1.7M–$23M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Leverage — Answering the Fundamental Question: "Where
  • Regent — We build all-electric, passenger-carrying, wing-in-ground-effect vehicles to service coastal routes with technology available today.
  • Bequest Finance — Succession and protection for digital assets. Trusts, Wills, Payable on Death, LLCs, tax efficient structuring for Crypto, Documents, Email data, and more.
Show all investments...

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 4 investments in Biotechnology startups, 12 in the past 12 months

Sahin Boydas is the Head of RemoteTeam at Gusto.

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Series A, Seed, Series B
  • Geography: United States, Mexico, Spain

Investor stats

  • Total investments: 68
  • Round size: Seed $4M–$34M; Series A $6M–$23M; Series B $23M–$70M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Postman — Postman is a complete API development environment, used by nearly six million developers and more than 200,000 companies worldwide. It offers a platform for developers or enterprises to build, test, and debug their APIs. The platform intends to use the funds to continue to expand operations and its business reach.Postman is an elegant, flexibletool used to build connected software via APIs quickly, easily, and accurately. It enables API-first development, automated testing, and developer onboarding. The platform's features simplify each step of building an API and streamline collaboration so they can create better APIs faster. Postman was founded in 2014 and is headquartered in San Francisco and has an office in Bangalore, where it was founded. Postman is privately held, with funding from Nexus Venture Partners.
  • Owner — Save Money By Converting Third Party Orders To Order Through Your Website. Build Your Customer Database. Increase Sales With Automatic Text and Email Marketing. Setup For You. Built In Loyalty.
  • Shield AI — AI pilots will revolutionize battlefields and commercial aviation at a scale greater than the self-driving movement reshaping our highways.
Show all investments...

Andrea Dusi
Angel · Verona, Veneto, Italy · 4 investments in Biotechnology startups

Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded Impactscool.He is advisor of dozens oftechnological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $911k–$6M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
  • BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 4 investments in Biotechnology startups

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $430k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Daren Cotter
Angel · Minneapolis, Minnesota, United States · 4 investments in Biotechnology startups

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 65
  • Round size: Seed $300k–$4M; Series A $3M–$10M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • TicketRev — TicketRev helps fans find cheaper tickets to their favorite games and concerts. Fans name their price for their preferred seating location, enabling resellers and teams to sell their inventory faster.
  • Fulcrum — Designed with technology in mind, be free of paper with Fulcrum, the manufacturing ERP of the future. Ai scheduling, visual BOM, live tracking
  • Vertical Insure — Vertical Insure is an insurance company built for vertical SaaS platforms.
Show all investments...

Max Levchin
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

Max Levchin is an investor and advisor to emerging technology companies. He was previously the chairman and chief executive officer of HVF, a startup lab focused on extracting insights from recordable information.Levchin co-founded Confinity Inc. in December 1998, and served as the Chief Technology Officer and a director. He also foundedNetMeridian Software, a developer of early Internet applications Levchin also serves as chairman of the boards of directors of Yelp Inc. and Kaggle Inc., and as a director of Evernote Corporation.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Mobile
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 107
  • Round size: Seed $1.3M–$7M; Series A $3.4M–$25M; Series B $9M–$116M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • withco — You deserve to own your business' real estate. We make it happen. Apply in 5 min to see if our lease-to-own partnership is right for you.
  • Pomelo — At Pomelo we build state-of-the-art fintech infrastructure. Our technology enables you to launch and scale your financial services business.
  • CoPilot — CoPilot is pioneering Assisted Commerce for big-ticket purchases – starting with cars. You are the one spending the money - shouldn't you have an expert on your side? We founded CoPilot to make that a reality. For the average car buyer, who is not a car expert or enthusiast, car shopping can be a time consuming, frustrating process that leavespeople feeling alone and disadvantaged. CoPilot is changing this dynamic. Like a trusted friend who is knowledgeable about cars, knows where to look and what to buy, CoPilot provides car shoppers with an expert partner who empowers them to discover the perfect car at the best possible price with ease and confidence.
Show all investments...

Annie Vereecken
Angel · 4 investments in Biotechnology startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Hospital
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Sake Bosch
Angel · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Biotechnology startups

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: The Netherlands, France, Israel

Investor stats

  • Total investments: 26
  • Round size: Seed $1.8M–$7M; Series A $6.9M–$20M; Series B $7M–$78M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Fairbrics — Fairbrics is developing the first synthetic fiber with a net positive impact on climate change and capable of meeting the demand of the market.
  • FononTech — FononTech specializes in impulse printing.It is used to print small electronic circuits for electronic devices.
  • Mermade Seafoods — Mermade is a pioneering cellular aquaculture company, bringing a novel approach and mindset for the production of cell based seafood.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Brad Flora
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

Brad Flora is a Visiting Partner at Y Combinator. He is a former Co-Founder and CEO of Perfect Audience. Mr. Flora received a BA from Princeton University in English and an MS in Journalism from Northwestern.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Mexico, India

Investor stats

  • Total investments: 72
  • Round size: Seed $350k–$3.6M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • SWAP — Swap empowers companies to transform their financial operation with an innovative approach, technology, and business model. SWAP’s APIs offer clients end-to-end, white-label, financial solutions. Connected to them, its clients are able to develop complete financial ecosystems including pre-paid cards, digital wallets, financial services and furthermonetize their platform while expanding their core experience. It removes barriers and generates new business lines for companies, effectively creating internal fintech.
  • Wallet.ng — Wallet.ng is a fintech startup that allows people and companies to send, receive, and make payments, using their phone numbers.The company's infrastructure also provides plugins and libraries for merchants to accept payments online with just a URL. Wallet.ng users can pay directly into bank accounts and Pay Utility Bills in Nigeria.Wallet.ng is a mobile payment solution, its core infrastructure is built using technologies which is adaptable for multiple countries across Africa.It was established in Lagos, Lagos by John Oluranti Oke and Joseph Benson-Aruna in 2018..
  • Wallets — Wallets Africa helps Africans and African-owned businesses send money, receive money, make card payments, and access overdrafts.
Show all investments...

Bill Gates
Angel · Seattle, Washington, United States · 4 investments in Biotechnology startups

Bill Gates is the founder, technology advisor, and board member of Microsoft Corporation, the worldwide leader in software, services, and solutions that help people and businesses realize their full potential. He served as chairman of the board until Feb. 4, 2014.On June 27, 2008, Gates transitioned out of a day-to-day role in the company tospend more time on his global health and education work at the Bill & Melinda Gates Foundation. He shares his thoughts about the foundation and other topics on Gates Notes, a website launched in January 2010. Gates continues to serve on Microsoft’s Board of Directors and as an advisor on key development projects. He is also the Founder of Breakthrough Energy.Born on Oct. 28, 1955, Gates grew up in Seattle with his two sisters. Their father, William H. Gates II, is a Seattle attorney. Their late mother, Mary Gates, was a schoolteacher, University of Washington regent, and chairwoman of United Way International.Gates attended public elementary school and the private Lakeside School. There, he discovered his interest in software and began programming computers at age 13.In 1973, Gates entered Harvard University as a freshman, where he lived down the hall from Steve Ballmer. While at Harvard, Gates developed a version of the programming language BASIC for the first microcomputer – the MITS Altair.In his junior year, Gates left Harvard to devote his energies to Microsoft, a company he had begun in 1975 with his childhood friend Paul Allen. Guided by a belief that the computer would be a valuable tool on every office desktop and in every home, they began developing software for personal computers. Gates’ foresight and his vision for personal computing have been central to the success of Microsoft and the software industry.Under Gates’ leadership, Microsoft’s mission has been to continually advance and improve software technology, and to make it easier, more cost-effective, and more enjoyable for people to use computers. The company is committed to a long-term view, reflected in its industry-leading investment in research and development each year.In 1999, Gates wrote Business @ the Speed of Thought, a book that shows how computer technology can solve business problems in fundamentally new ways. The book was published in 25 languages and is available in more than 60 countries. Business @ the Speed of Thought has received wide critical acclaim and was listed on the best-seller lists of the New York Times, USA Today, The Wall Street Journal, and Amazon.com. Gates’ previous book, The Road Ahead, published in 1995, was at the top of the New York Times bestseller list for seven weeks.Gates has donated the proceeds of both books to non-profit organizations that support the use of technology in education and skills development.In addition to his love of computers and software, Gates founded Corbis, which is developing one of the world’s largest resources of visual information – a comprehensive digital archive of art and photography from public and private collections around the globe. He is also a member of the board of directors of Berkshire Hathaway Inc., which invests in companies engaged in diverse business activities.Philanthropy is very important to Gates. He and his wife, Melinda, started a foundation in 2000 to help reduce inequities in the United States and around the world. The Bill & Melinda Gates Foundation supports philanthropic initiatives in the areas of global health and learning, with the hope that in the 21st century, advances in these critical areas will be available for all people. To learn more about the foundation, visit www.gatesfoundation.orgGates was married on Jan. 1, 1994, to Melinda French Gates. They have three children. Gates is an avid reader and enjoys playing golf, tennis, and bridge.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Manufacturing
  • Stage:Series A, Series C, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 92
  • Round size: Series A $12M–$100M; Series B $14M–$30M; Series C $14M–$83M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Mainspring Energy — Local power generation for the net-zero carbon grid.
  • Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
  • Inflection AI — We are an AI studio creating a personal AI for everyone.
Show all investments...

Brenton Saunders
Angel · Parsippany, New Jersey, United States · 4 investments in Biotechnology startups

Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 9
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Wondermind — Welcome to Wondermind, your home for approachable, expert-backed mental health content you can actually use.
  • Nucleus — Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
  • Lipidio Pharmaceuticals — Lipidio Pharmaceuticals is a healthcare company that focuses on advancing a molecule to treat diseases associated with excess body fat. It includes non-alcoholic steatohepatitis, Prader-Willi syndrome, and antipsychotic drug-induced weight gain. The company was founded in 2018 and headquartered in San Diego, California.
Show all investments...

David Beyer
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Enterprise Software
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 33
  • Round size: Seed $500k–$4M; Angel $1.5M–$2.2M; Series A $2.7M–$9M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Airtable — Airtable is a cloud-based software company that offers an easy-to-use online platform for creating and sharing relational databases.It brings the database out of the realm of power users and into the mainstream, creating a new type of flexible but sophisticated productivity tool that anyone can use. Airtable gives end-users the ability to createand share their own workflows for everything from managing an editorial calendar to planning a major event. The platform helps create flexible checklists, organize collections or ideas, and manage customers or contacts as well as offers a variety of templates ranging from home improvement to store inventory, enabling users to build custom applications without any prior coding experience.The company was founded by Andrew Ofstad, Emmett Nicholas, and Howie Liu in 2013 and is headquartered in San Francisco, California.
  • Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
  • Ginkgo Bioworks — Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria toprotect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.
Show all investments...

Arda Kara
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

Arda Kara

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 9
  • Round size: Series A $25M–$27M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
  • Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
  • Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
Show all investments...

Esther Dyson
Angel · New York, New York, United States · 4 investments in Biotechnology startups

Esther Dyson - Founder @ Way to Wellville

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A
  • Geography: United States, Canada, Russian Federation

Investor stats

  • Total investments: 68
  • Round size: Seed $100k–$2.5M; Series A $1M–$9.7M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Boxhub — Buy new & used shipping containers with Boxhub. We make buying a shipping container easy & deliver it right to your door. Buy a storage container today!
  • NeuroGeneces — NeuroGeneces is a seed-stage startup focused on improving memory and slowing cognitive decline while we age. We apply cutting-edge research in sleep and neuroscience to enhance the natural memory consolidation processes that occur during sleep. Our EEG-based headband and algorithms synchronize acoustic stimulus to the user’s Slow Oscillations(SOs) during slow wave sleep, which increases the memory recall.
  • Humanity — Slow down, or even, reverse your aging.
Show all investments...

Ling Wong
Angel · Seattle, Washington, United States · 4 investments in Biotechnology startups

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States

Investor stats

  • Total investments: 25
  • Round size: Series B $32M–$300M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
  • Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
  • Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 4 investments in Biotechnology startups

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 40
  • Round size: Seed $1.5M–$12M; Pre-Seed $123k–$1.4M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • The Garden — The Garden is an online media company.
  • Condense — Live-streamed volumetric video into game engines
Show all investments...

Elad Gil
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups, 20 in the past 12 months

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 170
  • Round size: Seed $2M–$7M; Series A $10M–$30M; Series B $20M–$75M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Resend — Build, test, and send transactional emails at scale.
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
  • Neon — Postgres made for developers. Easy to Use, Scalable, Cost efficient solution for your next project.
Show all investments...

Ethan Oren Perlstein
Angel · San Francisco, California, United States · 4 investments in Biotechnology startups

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Show more...

Investment focus

  • Industry: Biotechnology, Cannabis, Biopharma
  • Stage:Seed
  • Geography: United States, Canada

Investor stats

  • Total investments: 4
  • Round size: Seed $2M–$4.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
  • BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
  • Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.
Show all investments...

Biotechnology Angel investor funding at a glance

Stats across 1.3k deals from 1.3k investors.

1.3k
investors
in Biotechnology startups
1.3k
deals
in Biotechnology startups
$4.9M
median round
in Biotechnology startups
12%
lead investors
lead at least one round
36%
Seed
most common funding stage

Access all 1317 angel investors in Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 1317 angel investors investing in Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists